Determining the Minimal Clinical Important Difference for Medication Quantification Scale III and Morphine Milligram Equivalents in Patients with Failed Back Surgery Syndrome

Goudman, LisaDe Smedt, AnnForget, PatriceMoens, Maarten2020-12-042020-12-042020-11-21Goudman, L, De Smedt, A, Forget, P & Moens, M 2020, 'Determining the Minimal Clinical Important Difference for Medication Quantification Scale III and Morphine Milligram Equivalents in Patients with Failed Back Surgery Syndrome', Journal of Clinical Medicine, vol. 9, no. 11, 3747. https://doi.org/10.3390/jcm91137472077-0383ORCID: /0000-0001-5772-8439/work/84977707https://hdl.handle.net/2164/15454Funding: This study was supported by Medtronic Europe Sàrl through an independent research grant. Medtronic was not involved in the collection and analysis of the data or in writing the manuscript.9727323engminimal clinically important differenceclinical importanceresponsivenessR MedicineRDetermining the Minimal Clinical Important Difference for Medication Quantification Scale III and Morphine Milligram Equivalents in Patients with Failed Back Surgery SyndromeJournal article10.3390/jcm9113747911